Clinical Trials

280 enrolled

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT03486873 2026-06-05

MK-3475-587

Other hematologic neoplasm

3,500 enrolled

Hematologic Neoplasms

NCT04892173 2026-06-05

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT05438043 2026-06-05

A Study of Daratumumab

Multiple Myeloma

NCT05552222 2026-06-05

MajesTEC-7

1,590 enrolled

Multiple Myeloma

NCT05812807 2026-06-05

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

1,295 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT05902169 2026-06-05

SONOBIRD

560 enrolled

CNS

Glioblastoma

NCT06058377 2026-06-05

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

3,680 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT06152575 2026-06-05

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

492 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT06158841 2026-06-05

CERVINO

380 enrolled

Multiple Myeloma

NCT06208150 2026-06-05

MonumenTAL-6

795 enrolled

Multiple Myeloma

NCT06284122 2026-06-05

MorningLyte

790 enrolled

Lymphoid

Lymphoma, Follicular

NCT06319820 2026-06-05

MoonRISe-1

641 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06377852 2026-06-05

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Breast Neoplasms

NCT06422806 2026-06-05

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

365 enrolled

Sarcoma

Liposarcoma, Histiocytoma, Malignant Fibrous

NCT06629779 2026-06-05

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

900 enrolled

Metastatic Castration-Resistant Prostate Cancer

NCT06662786 2026-06-05

OrigAMI-2

1,000 enrolled

Colorectal Neoplasms

NCT06750094 2026-06-05

OrigAMI-3

700 enrolled

Colorectal Neoplasms

NCT06852222 2026-06-05

cAMeLot-2

Other hematologic neoplasm

600 enrolled

Leukemia, Myeloid, Acute

NCT06876714 2026-06-05

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

1,524 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT06901531 2026-06-05

LUCERNA

Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT06919965 2026-06-05

MoonRISe-3

220 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07028853 2026-06-05

MEVPRO-3

1,000 enrolled

Prostatic Neoplasms

NCT07061977 2026-06-05

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

336 enrolled

Gynecologic

Locally Advanced Cervical Adenocarcinoma

NCT07164443 2026-06-05

KLK2-comPAS

663 enrolled

Metastatic Castration-resistant Prostate Neoplasms

NCT07198074 2026-06-05

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

255 enrolled

Gynecologic

Endometrial Neoplasms

NCT07217587 2026-06-05

EPIC

115 enrolled

Myasthenia Gravis

NCT07225946 2026-06-05

KLK2-PASenger

800 enrolled

Prostatic Neoplasms, Castration-Resistant

NCT07258511 2026-06-05

TRIlogy-4

400 enrolled

Multiple Myeloma

NCT07276399 2026-06-05

OrigAMI-5

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07391774 2026-06-05

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

1,978 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT07429266 2026-06-05

INTREPID

250 enrolled

Myeloid

Polycythemia Vera

NCT07481149 2026-06-05

EX-CIPN

240 enrolled

Peripheral Nervous System Diseases

NCT07518186 2026-06-05

TRIlogy-5

700 enrolled

Multiple Myeloma

NCT03011684 2026-06-04

TALES

309 enrolled

Breast Neoplasms, Infertility

NCT05232916 2026-06-04

FLAMINGO-01

750 enrolled

Breast Neoplasms, Neoplasm, Residual

NCT05243797 2026-06-04

MajesTEC-4

1,594 enrolled

Multiple Myeloma

NCT05253651 2026-06-04

MOUNTAINEER-03

400 enrolled

Colorectal Neoplasms

NCT05920356 2026-06-04

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

750 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06065748 2026-06-04

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

1,050 enrolled

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

NCT06235151 2026-06-04

Solar-Stage

439 enrolled

Prostatic Neoplasms

NCT06615479 2026-06-04

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

440 enrolled

Multiple Myeloma, Recurrence

NCT06626022 2026-06-04

MUSIC-Screen

1,284 enrolled

Prostate Cancer Screening

NCT06943872 2026-06-04

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

LymphoidOther hematologic neoplasm

630 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07005128 2026-06-04

DeLLphi-312

330 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07174336 2026-06-04

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

920 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07213674 2026-06-04

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

750 enrolled

Prostatic Neoplasms

NCT07222566 2026-06-04

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

1,410 enrolled

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT07222800 2026-06-04

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

800 enrolled